Financing
Debt Issuance Proceeds
Medline, Inc. Debt Issuance Proceeds remained flat by 0.0% to $1.89B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 52.5%, from $3.98B to $1.89B.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLeverage
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
High issuance can signal expansion plans or a strategy to take advantage of low interest rates, but also increases future interest obligations.
Detailed definition
The total cash proceeds received from the sale of bonds, notes, or other debt instruments. This represents an increase i...
Peer comparison
Companies often issue debt even when they have cash to optimize their weighted average cost of capital (WACC).
Metric ID:
debt_issuanceHistorical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $0.00 | $15.93B | $7.57B |
| YoY Change | — | — | -52.5% |
Range$0.00 – $15.93B
Avg YoY Growth-52.5%
Median YoY Growth-52.5%
Debt Issuance Proceeds at Other Companies
Frequently Asked Questions
- What is Medline, Inc. 's debt issuance proceeds?
- Medline, Inc. (MDLN) reported debt issuance proceeds of $1.89B in Q4 2025.
- How has Medline, Inc. 's debt issuance proceeds changed year-over-year?
- Medline, Inc. 's debt issuance proceeds decreased by 52.5% year-over-year, from $3.98B to $1.89B.
- What does debt issuance proceeds mean?
- The amount of new money a company borrowed by issuing bonds or taking out loans.